Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
3.150
+0.125 (4.13%)
At close: Sep 15, 2025, 4:00 PM EDT
3.210
+0.060 (1.90%)
After-hours: Sep 15, 2025, 7:09 PM EDT
Rapid Micro Biosystems Market Cap
Rapid Micro Biosystems has a market cap or net worth of $139.26 million as of September 15, 2025. Its market cap has increased by 280.66% in one year.
Market Cap
139.26M
Enterprise Value
115.73M
1-Year Change
280.66%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since the IPO on July 15, 2021, Rapid Micro Biosystems's market cap has decreased from $799.07M to $139.26M, a decrease of -82.57%. That is a compound annual growth rate of -34.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 133.74M | 245.30% |
| Dec 31, 2024 | 38.73M | 23.41% |
| Dec 29, 2023 | 31.38M | -33.87% |
| Dec 30, 2022 | 47.45M | -89.21% |
| Dec 31, 2021 | 439.99M | -44.94% |
| Jul 15, 2021 | 799.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |